Research Study

A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Principal Investigator 
John Swiston

Overview

Body Locations and Systems 
High Blood Pressure
ClinicalTrials.gov# 
NCT02657356
Status 
Recruiting
Study Start/End 
Dec 7, 2016 to Dec 31, 2018
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Dennis Solomon, Research Coordinator
Phone 
604-875-4111 ext.69831
Purpose of Study 

This study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with connective tissue disease-associated pulmonary arterial hypertension to determine the recommended dose range and evaluate the change from baseline in 6-minute walk distance (6MWD) following 24 weeks of study participation.

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.